About Tesio
Tesio is Developing the Next Generation of Anti-inflammatory Products with Kinase Inhibition and State-of-the-art Targeted Drug Delivery
Our technology targets the master checkpoint common to all inflammatory pathways to outperform conventional therapeutics
Targeted long-acting injections provide relief without systemic exposure or steroid side-effects
Lead indication is Osteoarthritis, the nation’s most common cause of disability